Recent advances in the molecular genetics of primary gliomas

被引:74
作者
Kitange, GJ [1 ]
Templeton, KL [1 ]
Jenkins, RB [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Lab Genet, Rochester, MN 55905 USA
关键词
D O I
10.1097/00001622-200305000-00003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary brain tumors, particularly glioblastomas, remain a challenge for oncology. Uncontrolled cellular proliferation, lack of apoptosis, invasion, and angiogenesis are among the biologic processes that render these tumors both aggressive and difficult to treat. An understanding of the genetics and molecular events regulating these aggressive tumors is beginning to emerge, partly because of recent knowledge in genomics, gene expression analysis, and mouse tumor models As a result, it is now generally accepted that brain tumors, particularly those arising from cells of glial lineage, result from stepwise accumulation of deleterious genetic alterations. Several genetic abnormalities have been described, and current research is aimed at elucidating their causal association with brain tumor formation and progression. The purpose of this review is to summarize some of the most important recently published findings on the molecular genetics of primary gliomas. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 62 条
  • [1] Epidermal growth factor receptor and Ink4a/Arf:: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis
    Bachoo, RM
    Maher, EA
    Ligon, KL
    Sharpless, NE
    Chan, SS
    You, MJJ
    Tang, Y
    DeFrances, J
    Stover, E
    Weissleder, R
    Rowitch, DH
    Louis, DN
    DePinho, RA
    [J]. CANCER CELL, 2002, 1 (03) : 269 - 277
  • [2] EGFR overexpression and radiation response in glioblastoma multiforme
    Barker, FG
    Simmons, ML
    Chang, SM
    Prados, MD
    Larson, DA
    Sneed, PK
    Wara, WM
    Berger, MS
    Chen, PC
    Israel, MA
    Aldape, KD
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (02): : 410 - 418
  • [3] Barth RF, 2002, CANCER RES, V62, P3159
  • [4] Cisplatin-induced activation of the EGF receptor
    Benhar, M
    Engelberg, D
    Levitzki, A
    [J]. ONCOGENE, 2002, 21 (57) : 8723 - 8731
  • [5] Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation
    Brat, DJ
    Castellano-Sanchez, A
    Kaur, B
    Van Meir, EG
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2002, 9 (01) : 24 - 36
  • [6] Genetics and new approaches to cancer therapy - Commentary
    Cavenee, WK
    [J]. CARCINOGENESIS, 2002, 23 (05) : 683 - 686
  • [7] Chakravarti A, 2002, CANCER RES, V62, P4307
  • [8] Choe GY, 2002, CLIN CANCER RES, V8, P2894
  • [9] Cellular mechanisms targeted during astrocytoma progression
    Collins, VP
    [J]. CANCER LETTERS, 2002, 188 (1-2) : 1 - 7
  • [10] Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients:: Preliminary study
    Crombet, T
    Torres, O
    Rodríguez, V
    Menéndez, A
    Stevenson, A
    Ramos, M
    Torres, F
    Figueredo, R
    Veitía, I
    Iznaga, N
    Pérez, R
    Lage, A
    [J]. HYBRIDOMA, 2001, 20 (02): : 131 - 136